{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:03:30Z","timestamp":1774062210833,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11596-025-00009-3","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:51:52Z","timestamp":1740120712000},"page":"114-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting Glycolytic Enzymes with 3-Bromopyruvic Acid to Enhance the Efficacy of Interventional Embolization in Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"45","author":[{"given":"Min","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-peng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuang-lin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-lin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"issue":"9822","key":"9_CR1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245\u20131255.","journal-title":"Lancet"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"1100079","DOI":"10.3389\/fimmu.2023.1100079","volume":"14","author":"L Chen","year":"2023","unstructured":"Chen L, Zhang R, Lin Z, et al. Radiation therapy in the era of immune treatment for hepatocellular carcinoma. Front Immunol. 2023;14:1100079.","journal-title":"Front Immunol"},{"issue":"12","key":"9_CR3","doi-asserted-by":"publisher","first-page":"8669","DOI":"10.1007\/s00330-023-09754-2","volume":"33","author":"ZC Jin","year":"2023","unstructured":"Jin ZC, Zhong BY, Chen JJ, et al. Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study. Eur Radiol. 2023;33(12):8669\u20138681.","journal-title":"Eur Radiol"},{"issue":"6","key":"9_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/00015458.2023.2256539","volume":"123","author":"KS Chan","year":"2023","unstructured":"Chan KS, Tay WX, Cheo FY, et al. Preoperative transarterial chemoembolization (TACE) + liver resection versus upfront liver resection for large hepatocellular carcinoma (\u22655 cm): a systematic review and meta-analysis. Acta Chir Belg. 2023;123(6):601\u2013617.","journal-title":"Acta Chir Belg"},{"key":"9_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122540","volume":"342","author":"J Li","year":"2024","unstructured":"Li J, Liu Y, Zheng R, et al. Molecular mechanisms of TACE refractoriness: Directions for improvement of the TACE procedure. Life Sci. 2024;342:122540.","journal-title":"Life Sci"},{"issue":"8","key":"9_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/ph17081057","volume":"17","author":"Z Wang","year":"2024","unstructured":"Wang Z, Li Q, Liang B. Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma. Pharmaceuticals (Basel). 2024;17(8):1057.","journal-title":"Pharmaceuticals (Basel)"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2147\/JHC.S454698","volume":"11","author":"S Zong","year":"2024","unstructured":"Zong S, Huang G, Pan B, et al. A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2024;11:525\u2013542.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"9_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2049-3002-2-4","volume":"2","author":"SD Stuart","year":"2014","unstructured":"Stuart SD, Schauble A, Gupta S, et al. A strategically designed small molecule attacks alpha-ketoglutarate dehydrogenase in tumor cells through a redox process. Cancer Metab. 2014;2(1):4.","journal-title":"Cancer Metab"},{"issue":"12","key":"9_CR9","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2174\/1871520623666230406111833","volume":"23","author":"JM Pan","year":"2023","unstructured":"Pan JM, Li JC, Yang C, et al. 3-Bromopyruvate Inhibits the Growth and Glucose Metabolism of TNBC Xenografts in Nude Mice by Targeting c-Myc. Anticancer Agents Med Chem. 2023;23(12):1421\u20131428.","journal-title":"Anticancer Agents Med Chem"},{"issue":"2","key":"9_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3892\/etm.2022.11447","volume":"24","author":"J Li","year":"2022","unstructured":"Li J, Pan J, Liu Y, et al. 3-Bromopyruvic acid regulates glucose metabolism by targeting the c-Myc\/TXNIP axis and induces mitochondria-mediated apoptosis in TNBC cells. Exp Ther Med. 2022;24(2):520.","journal-title":"Exp Ther Med"},{"issue":"1","key":"9_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0304-3835(01)00667-X","volume":"173","author":"YH Ko","year":"2001","unstructured":"Ko YH, Pedersen PL, Geschwind JF. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett. 2001;173(1):83\u201391.","journal-title":"Cancer Lett"},{"issue":"12","key":"9_CR12","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0006-2952(02)01456-9","volume":"64","author":"H Liu","year":"2002","unstructured":"Liu H, Savaraj N, Priebe W, et al. Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (Model C). Biochem Pharmacol. 2002;64(12):1745\u20131751.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"9_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00280-003-0724-7","volume":"53","author":"JC Maher","year":"2004","unstructured":"Maher JC, Krishan A, Lampidis TJ. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemother Pharmacol. 2004;53(2):116\u2013122.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"9_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1158\/0008-5472.613.65.2","volume":"65","author":"RH Xu","year":"2005","unstructured":"Xu RH, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005;65(2):613\u2013621.","journal-title":"Cancer Res"},{"issue":"3","key":"9_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jhep.2004.11.020","volume":"42","author":"GY Gwak","year":"2005","unstructured":"Gwak GY, Yoon JH, Kim KM, et al. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J Hepatol. 2005;42(3):358\u2013364.","journal-title":"J Hepatol"},{"issue":"1","key":"9_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10863-012-9428-1","volume":"44","author":"C Pinheiro","year":"2012","unstructured":"Pinheiro C, Longatto-Filho A, Azevedo-Silva J, et al. Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr. 2012;44(1):127\u2013139.","journal-title":"J Bioenerg Biomembr"},{"issue":"6","key":"9_CR17","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3348\/kjr.2009.10.6.596","volume":"10","author":"HJ Jae","year":"2009","unstructured":"Jae HJ, Chung JW, Park HS, et al. The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model. Korean J Radiol. 2009;10(6):596\u2013603.","journal-title":"Korean J Radiol"},{"issue":"1","key":"9_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10863-012-9408-5","volume":"44","author":"AT de Oliveira","year":"2012","unstructured":"de Oliveira AT, Pinheiro C, Longatto-Filho A, et al. Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs). J Bioenerg Biomembr. 2012;44(1):171\u2013178.","journal-title":"J Bioenerg Biomembr"},{"issue":"20","key":"9_CR19","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1002\/cncr.24532","volume":"115","author":"M Thangaraju","year":"2009","unstructured":"Thangaraju M, Karunakaran SK, Itagaki S, et al. Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate. Cancer. 2009;115(20):4655\u20134666.","journal-title":"Cancer"},{"issue":"14","key":"9_CR20","first-page":"3909","volume":"62","author":"JF Geschwind","year":"2002","unstructured":"Geschwind JF, Ko YH, Torbenson MS, et al. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res. 2002;62(14):3909\u20133913.","journal-title":"Cancer Res"},{"issue":"1","key":"9_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10863-012-9422-7","volume":"44","author":"S Cardaci","year":"2012","unstructured":"Cardaci S, Desideri E, Ciriolo MR. Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug. J Bioenerg Biomembr. 2012;44(1):17\u201329.","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"9_CR22","first-page":"13","volume":"33","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Kunjithapatham R, Geschwind JF. Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting. Anticancer Res. 2013;33(1):13\u201320.","journal-title":"Anticancer Res"},{"issue":"3","key":"9_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3348\/kjr.2007.8.3.216","volume":"8","author":"HS Park","year":"2007","unstructured":"Park HS, Chung JW, Jae HJ, et al. FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor model. Korean J Radiol. 2007;8(3):216\u2013224.","journal-title":"Korean J Radiol"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00009-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-025-00009-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00009-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T07:35:42Z","timestamp":1741851342000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-025-00009-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1007\/s11596-025-00009-3","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All animal experiments were approved by the Experimental Animal Ethics Committee of Huazhong University of Science and Technology\u00a0(IACUC Approval Number:\u00a02455).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"This manuscript has not been published or presented elsewhere in part or in entirety and is not under consideration by another journal. All authors have approved the manuscript and agreed to submit it for publication in Current Medical Science.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}